GlassScriptPhysician profile
Steven Peskin
NPI 1215032263
$98,699.25
in general payments reported to CMS, 2019-2025
19 companies · $3,000 in 2025
The $3,000 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,383 · 2020: $2,395 · 2021: $5,308 · 2022: $46K · 2023: $30K · 2024: $3,960 · 2025: $3,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $26K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Travel and Lodging: $1,260 · Food and Beverage: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,760.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,000.00 |
| Travel and Lodging | $1,259.62 |
| Food and Beverage | $173.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurometrix INC | $30,000.00 | 2022-2023 | |
| Medtronic, INC. | $10,960.00 | 2023-2024 | |
| Novo Nordisk As | $8,745.20 | 2023 | |
| Pear Therapeutics (US), INC. | $8,400.00 | 2022 | |
| Genzyme Corporation | $7,383.49 | 2019 | |
| Pfizer INC. | $5,424.17 | 2022 | |
| Glaxosmithkline, LLC. | $5,125.00 | 2023-2025 | |
| Dexcom, INC. | $3,015.00 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,600.00 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $2,502.50 | 2021 | |
| Illumina, INC. | $2,433.82 | 2022 | |
| Novo Nordisk INC | $2,200.00 | 2022 | |
| Abbvie INC. | $2,152.82 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $1,776.00 | 2020 | |
| Genentech, INC. | $1,455.00 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Uswm, LLC | $1,350.00 | 2021 | |
| Roche Molecular Systems, INC. | $1,312.50 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $1,245.00 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $618.75 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Peskin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.